High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Cancer Discovery|2025Cited by 16
Abstract 3696: Liquid biopsy biomarker analysis during treatment with 177Lu-PSMA-617 in castrate resistant prostate cancerJamie M. Sperger, Joshua M. Lang, Marina N. Sharifi et al.|Cancer Research|2024Cited by 1
Abstract B042: Molecular assessment of cell surface targets using integrated circulating tumor cell (CTC) RNAseq and single CTC phenotypingJamie M. Sperger, Joshua M. Lang, Marina N. Sharifi et al.|Clinical Cancer Research|2024Cited by 0
Abstract B041: High purity CTC RNA sequencing identifies poor prognosis lineage states in castrate resistant prostate cancerMarina N. Sharifi, Joshua M. Lang, Jamie M. Sperger et al.|Clinical Cancer Research|2024Cited by 0
Abstract 1976: Circulating tumor cell (CTC) RNA sequencing and single cell protein phenotyping reveal heterogeneity of cell surface target expression in metastatic prostate cancer CTCsAlex H. Chang, Marina N. Sharifi, Jamie M. Sperger et al.|Cancer Research|2025Cited by 0